Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Insan Co., Ltd. is a South Korean healthcare company specializing in the production and distribution of traditional Korean medicinal products, most notably bamboo salt (Jukyeom). Founded in 1986 based on the teachings of Dr. Kim Il-hoon (Insan), the company utilizes a unique nine-time roasting process to create mineral-rich salt products intended for therapeutic use. Beyond bamboo salt, Insan offers a variety of health supplements, including roasted garlic and herbal extracts, aimed at promoting general wellness and addressing inflammatory conditions. The company is publicly traded on the KOSDAQ and operates globally, with a significant presence in the United States through its subsidiary Insan Healing. Insan is recognized as a pioneer in the commercialization of traditional Korean wellness products and maintains rigorous quality control through its specialized manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INSAN.